Joint tenderness and ultrasound inflammation in DMARD-naïve patients with early rheumatoid arthritis
- 3 June 2021
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 80 (11), 1493-1494
- https://doi.org/10.1136/annrheumdis-2021-220265
Abstract
No abstract availableFunding Information
- Pfizer (NA)
- Norwegian South-Eastern Health Region (2011081, 2019003)
- Roche Norway AS (NA)
- Norges Forskningsråd (213503)
- Norske Kvinners Sanitetsforening (H3/2011)
- AbbVie AS (NA)
- MDS Norway AS (NA)
- UCB Pharma AS (NA)
- Norsk Revmatikerforbund (NA)
This publication has 7 references indexed in Scilit:
- Role of joint damage, malalignment and inflammation in articular tenderness in rheumatoid arthritis, psoriatic arthritis and osteoarthritisAnnals Of The Rheumatic Diseases, 2021
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateAnnals Of The Rheumatic Diseases, 2020
- Swollen, but not tender joints, are independently associated with ultrasound synovitis: results from a longitudinal observational study of patients with established rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2019
- SAT0208 TEN-YEAR OVERALL SURVIVAL AND STANDARIZED MORTALITY RATIO IN THE LARGEST SINGLE CENTER COHORT OF PATIENTS WITH PRIMARY SJOGREN’S ASSOCIATED LYMPHOMASAnnals Of The Rheumatic Diseases, 2019
- Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocolRheumatology, 2018
- Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trialBMJ, 2016
- Editorial Review (Thematic Issue: An Update on Central Sensitivity Syndromes and the Issues of Nosology and Psychobiology)Current Rheumatology Reviews, 2015